3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Recurrence
2
Breast Neoplasms
2
Stage IIIb and IV Non Small Cell Lung Cancer
1
Solid Tumor, Adult
1
Rare Diseases
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplastic Syndromes, Hereditary
1
Neoplasm, Residual
1
Multiple Myeloma
1
Mouth Neoplasms
1
Microsatellite Instability
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Medullary
1
COVID-19
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Surveys and Questionnaires
3
Blood Specimen Collection
3
Salpingo-oophorectomy
2
Genetic Testing
2
Genetic Counseling
2
Diet, Mediterranean
2
Counseling
2
Videotape Recording
1
Telemedicine
1
Tamoxifen
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Salpingectomy
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Palliative Care
1
Ovariectomy
1
Methods
1
Letrozole
1
Hysterectomy
1
High-Throughput Nucleotide Sequencing
1
Genotype
1
Exercise Test
1
Echocardiography
1
Early Intervention, Educational
1
CA-125 Antigen
1
Buthionine Sulfoximine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hereditary Breast and Ovarian Cancer Syndrome
×
High-Throughput Nucleotide Sequencing
×
Clear all
NCT04261972
2026-01-14
CHARM1
University Health Network, Toronto
Active not recruiting
1,416 enrolled